AI assistant
Sending…
Zai Lab Ltd — Director's Dealing 2023
Apr 5, 2023
31208_dirs_2023-04-05_2bd45885-eb0c-4abc-9fc4-aa84b6d1df43.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zai Lab Ltd (ZLAB)
CIK: 0001704292
Period of Report: 2023-04-03
Reporting Person: Du Ying (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-04-03 | Stock Options (Right to Buy) | $33.95 | A | 377391 | Acquired | 2033-04-03 | American Depositary Shares (377391) | Direct |
Footnotes
F1: The Stock Options are exercisable for American Depositary Shares (ADSs). The number of securities underlying each option and the exercise price therefor are represented in ADSs. Each ADS represents ten Ordinary Shares of the issuer.
F2: The Stock Options vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant.
F3: Each ADS represents ten Ordinary Shares of the issuer.
More from Zai Lab Ltd
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 13